Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: The Chinese University of Hong Kong

Does COVID-19 Impact the Microbiome? A Study Sponsored by the Gut Microbiota Research Center at the Chinese University of Hong Kong Says Yes

Research led by investigators from the Center for Gut Microbiota Research, the Chinese University of Hong Kong, pursued a recent […]

Does COVID-19 Impact the Microbiome A Study Sponsored by the Gut Microbiota Research Center at the Chinese University of Hong Kong Says Yes
1 week ago
Share

Hong Kong Researchers Establish Likely Connection Between Microbiome & Severity Levels of COVID-19

Hong Kong-based researchers have established that the gut microbiome is likely associated with the severity of SARS-CoV-2, the virus behind […]

Hong Kong Researchers Establish Likely Connection Between Microbiome & Severity Levels of COVID-19
2 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.